Bilatu
2-tik 1-2 emaitza erakusten
Healthcare costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component = Costes de la atención de los cánceres de mama, próstata, colorrectal y pulmón por estadio clínico y componente de coste
(Elsevier España, S.L.U., 2021)
Objective: To measure 3-year care costs of breast, prostate, colorectal and lung cancers disaggregated bysite and clinical stage.Method: A retrospective observational design was employed to investigate care costs of cases ...
Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis
(BioMed Central Ltd, 2016)
Background
Breast cancer screening in the Basque Country has shown 20 % reduction of the number of BC deaths and an acceptable overdiagnosis level (4 % of screen detected BC). The aim of this study was to evaluate the ...